Lopez J, Lai-Kwon J, Molife R, Welsh L, et al. A Phase 1/2A trial of idroxioleic acid: first-in-class sphingolipid regulator and glioma cell autophagy inducer with antitumor activity in refractory glioma. Br J Cancer 2023 Jul 24. doi: 10.1038/s41416-023-02356.
PMID: 37488446